{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-inflammatory", "anti-obesity", "antidiabetic", "antihypertensive", "berberine", "isoquinoline alkaloid", "non-alcoholic fatty liver disease"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35744831", "DateCompleted": {"Year": "2022", "Month": "06", "Day": "27"}, "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "06", "Day": "09"}], "Language": ["eng"], "ELocationID": ["3705", "10.3390/molecules27123705"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "12", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "09"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.", "Abstract": {"AbstractText": ["Traditionally, herbal compounds have been the focus of scientific interest for the last several centuries, and continuous research into their medicinal potential is underway. Berberine (BBR) is an isoquinoline alkaloid extracted from plants that possess a broad array of medicinal properties, including anti-diarrheal, anti-fibrotic, antidiabetic, anti-inflammatory, anti-obesity, antihyperlipidemic, antihypertensive, antiarrhythmic, antidepressant, and anxiolytic effects, and is frequently utilized as a traditional Chinese medicine. BBR promotes metabolisms of glucose and lipids by activating adenosine monophosphate-activated protein kinase, stimulating glycolysis and inhibiting functions of mitochondria; all of these ameliorate type 2 diabetes mellitus. BBR has also been shown to have benefits in congestive heart failure, hypercholesterolemia, atherosclerosis, non-alcoholic fatty liver disease, Alzheimer's disease, and polycystic ovary syndrome. BBR has been investigated as an interesting pharmacophore with the potential to contribute significantly to the research and development of novel therapeutic medicines for a variety of disorders. Despite its enormous therapeutic promise, the clinical application of this alkaloid was severely limited because of its unpleasant pharmacokinetic characteristics. Poor bioavailability, limited absorption, and poor water solubility are some of the obstacles that restricted its use. Nanotechnology has been suggested as a possible solution to these problems. The present review aims at recent updates on important therapeutic activities of BBR and different types of nanocarriers used for the delivery of BBR in different diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India."}], "LastName": "Behl", "ForeName": "Tapan", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India."}], "LastName": "Singh", "ForeName": "Sukhbir", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India."}], "LastName": "Sharma", "ForeName": "Neelam", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India."}], "LastName": "Zahoor", "ForeName": "Ishrat", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Rehabilitation Health Sciences College of Applied Medical Sciences, King Saud University, Riyadh 145111, Saudi Arabia."}], "LastName": "Albarrati", "ForeName": "Ali", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia."}], "LastName": "Albratty", "ForeName": "Mohammed", "Initials": "M"}, {"Identifier": ["0000-0002-6876-7270"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacy Practice Research Unit, Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan 45124, Saudi Arabia."}], "LastName": "Meraya", "ForeName": "Abdulkarim M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry and Pharmacognosy, College of Pharmacy, Jazan University, Jazan 45142, Saudi Arabia."}], "LastName": "Najmi", "ForeName": "Asim", "Initials": "A"}, {"Identifier": ["0000-0003-3236-1292"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania."}, {"Identifier": [], "Affiliation": "Doctoral School of Biomedical Sciences, University of Oradea, 410087 Oradea, Romania."}], "LastName": "Bungau", "ForeName": "Simona", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Pharmaceutical Preparations"}, {"RegistryNumber": "0I8Y3P32UF", "NameOfSubstance": "Berberine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["pharmacokinetics", "therapeutic use"], "DescriptorName": "Berberine"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Nanotechnology"}, {"QualifierName": [], "DescriptorName": "Pharmaceutical Preparations"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83:770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Li G., Lou H. Strategies to Diversify Natural Products for Drug Discovery. Med. Res. Rev. 2018;38:1255\u20131294.", "ArticleIdList": ["29064108"]}, {"Citation": "Rishton G.M. Natural Products as a Robust Source of New Drugs and Drug Leads: Past Successes and Present Day Issues. Am. J. Cardiol. 2008;101:S43\u2013S49. doi: 10.1016/j.amjcard.2008.02.007.", "ArticleIdList": ["10.1016/j.amjcard.2008.02.007", "18474274"]}, {"Citation": "Rungsung W., Ratha K.K., Dutta S., Dixit A.K., Hazra J. Secondary Metabolites of Plants in Drugs Discovery. World J. Pharm. Res. 2015;4:604\u2013613."}, {"Citation": "Christodoulou M.-I., Tchoumtchoua J., Skaltsounis A.-L., Scorilas A., Halabalaki M. Natural Alkaloids Intervening the Insulin Pathway: New Hopes for Anti-Diabetic Agents? Curr. Med. Chem. 2019;26:5982\u20136015. doi: 10.2174/0929867325666180430152618.", "ArticleIdList": ["10.2174/0929867325666180430152618", "29714135"]}, {"Citation": "Shi Q.I.U., Hui S.U.N., Zhang A.-H., Hong-Ying X.U., Guang-Li Y.A.N., Ying H.A.N., Xi-Jun W. Natural Alkaloids: Basic Aspects, Biological Roles, and Future Perspectives. Chin. J. Nat. Med. 2014;12:401\u2013406.", "ArticleIdList": ["24969519"]}, {"Citation": "Qing Z.-X., Yang P., Tang Q., Cheng P., Liu X.-B., Zheng Y., Liu Y.-S., Zeng J.-G. Isoquinoline Alkaloids and Their Antiviral, Antibacterial, and Antifungal Activities and Structure-Activity Relationship. Curr. Org. Chem. 2017;21:1920\u20131934. doi: 10.2174/1385272821666170207114214.", "ArticleIdList": ["10.2174/1385272821666170207114214"]}, {"Citation": "Imanshahidi M., Hosseinzadeh H. Pharmacological and Therapeutic Effects of Berberis Vulgaris and Its Active Constituent, Berberine. Phyther. Res. 2008;22:999\u20131012. doi: 10.1002/ptr.2399.", "ArticleIdList": ["10.1002/ptr.2399", "18618524"]}, {"Citation": "Zuo F., Nakamura N., Akao T., Hattori M. Pharmacokinetics of Berberine and Its Main Metabolites in Conventional and Pseudo Germ-Free Rats Determined by Liquid Chromatography/Ion Trap Mass Spectrometry. Drug Metab. Dispos. 2006;34:2064\u20132072.", "ArticleIdList": ["16956957"]}, {"Citation": "Komal S., Ranjan B., Neelam C., Birendra S., Kumar S.N. Berberis Aristata: A Review. Int. J. Res. Ayurveda Pharm. 2011;2:383\u2013388."}, {"Citation": "Caliceti C., Franco P., Spinozzi S., Roda A., FG Cicero A. Berberine: New Insights from Pharmacological Aspects to Clinical Evidences in the Management of Metabolic Disorders. Curr. Med. Chem. 2016;23:1460\u20131476. doi: 10.2174/0929867323666160411143314.", "ArticleIdList": ["10.2174/0929867323666160411143314", "27063256"]}, {"Citation": "Tillhon M., Ortiz L.M.G., Lombardi P., Scovassi A.I. Berberine: New Perspectives for Old Remedies. Biochem. Pharmacol. 2012;84:1260\u20131267. doi: 10.1016/j.bcp.2012.07.018.", "ArticleIdList": ["10.1016/j.bcp.2012.07.018", "22842630"]}, {"Citation": "Bhowmik D., Suresh Kumar G. Recent Advances in Nucleic Acid Binding Aspects of Berberine Analogs and Implications for Drug Design. Mini Rev. Med. Chem. 2016;16:104\u2013109. doi: 10.2174/1389557515666150909144425.", "ArticleIdList": ["10.2174/1389557515666150909144425", "26349491"]}, {"Citation": "Derosa G., D\u2019Angelo A., Bonaventura A., Bianchi L., Romano D., Maffioli P. Effects of Berberine on Lipid Profile in Subjects with Low Cardiovascular Risk. Expert Opin. Biol. Ther. 2013;13:475\u2013482. doi: 10.1517/14712598.2013.776037.", "ArticleIdList": ["10.1517/14712598.2013.776037", "23441841"]}, {"Citation": "Battu S.K., Repka M.A., Maddineni S., Chittiboyina A.G., Avery M.A., Majumdar S. Physicochemical Characterization of Berberine Chloride: A Perspective in the Development of a Solution Dosage Form for Oral Delivery. Aaps Pharmscitech. 2010;11:1466\u20131475. doi: 10.1208/s12249-010-9520-y.", "ArticleIdList": ["10.1208/s12249-010-9520-y", "PMC2974104", "20842541"]}, {"Citation": "Huang C., Huang Z., Ho F., Chan W. Berberine Impairs Embryonic Development in Vitro and in Vivo through Oxidative Stress-mediated Apoptotic Processes. Environ. Toxicol. 2018;33:280\u2013294. doi: 10.1002/tox.22515.", "ArticleIdList": ["10.1002/tox.22515", "29168595"]}, {"Citation": "Gaba S., Saini A., Singh G., Monga V. An Insight into the Medicinal Attributes of Berberine Derivatives: A Review. Bioorg. Med. Chem. 2021;38:116143. doi: 10.1016/j.bmc.2021.116143.", "ArticleIdList": ["10.1016/j.bmc.2021.116143", "33848698"]}, {"Citation": "Feng X., Wang K., Cao S., Ding L., Qiu F. Pharmacokinetics and Excretion of Berberine and Its Nine Metabolites in Rats. Front. Pharmacol. 2021;11:2238. doi: 10.3389/fphar.2020.594852.", "ArticleIdList": ["10.3389/fphar.2020.594852", "PMC7874128", "33584274"]}, {"Citation": "Pan G., Wang G., Liu X., Fawcett J.P., Xie Y. The Involvement of P-glycoprotein in Berberine Absorption. Pharmacol. Toxicol. 2002;91:193\u2013197. doi: 10.1034/j.1600-0773.2002.t01-1-910403.x.", "ArticleIdList": ["10.1034/j.1600-0773.2002.t01-1-910403.x", "12530470"]}, {"Citation": "Ma J., Feng R., Tan X., Ma C., Shou J., Fu J., Huang M., He C., Chen S., Zhao Z. Excretion of Berberine and Its Metabolites in Oral Administration in Rats. J. Pharm. Sci. 2013;102:4181\u20134192. doi: 10.1002/jps.23718.", "ArticleIdList": ["10.1002/jps.23718", "24006193"]}, {"Citation": "Wang X., Wang R., Xing D., Su H., Ma C., Ding Y., Du L. Kinetic Difference of Berberine between Hippocampus and Plasma in Rat after Intravenous Administration of Coptidis Rhizoma Extract. Life Sci. 2005;77:3058\u20133067. doi: 10.1016/j.lfs.2005.02.033.", "ArticleIdList": ["10.1016/j.lfs.2005.02.033", "15996686"]}, {"Citation": "Wang X., Xing D., Wang W., Su H., Tao J., Du L. Pharmacokinetics of Berberine in Rat Thalamus after Intravenous Administration of Coptidis Rhizoma Extract. Am. J. Chin. Med. 2005;33:935\u2013943. doi: 10.1142/S0192415X05003557.", "ArticleIdList": ["10.1142/S0192415X05003557", "16355450"]}, {"Citation": "Tan X.-S., Ma J.-Y., Feng R., Ma C., Chen W.-J., Sun Y.-P., Fu J., Huang M., He C.-Y., Shou J.-W. Tissue Distribution of Berberine and Its Metabolites after Oral Administration in Rats. PLoS ONE. 2013;8:e77969. doi: 10.1371/journal.pone.0077969.", "ArticleIdList": ["10.1371/journal.pone.0077969", "PMC3815028", "24205048"]}, {"Citation": "Qiu F., Zhu Z., Kang N., Piao S., Qin G., Yao X. Isolation and Identification of Urinary Metabolites of Berberine in Rats and Humans. Drug Metab. Dispos. 2008;36:2159\u20132165. doi: 10.1124/dmd.108.021659.", "ArticleIdList": ["10.1124/dmd.108.021659", "18703644"]}, {"Citation": "Liu C.-S., Zheng Y.-R., Zhang Y.-F., Long X.-Y. Research Progress on Berberine with a Special Focus on Its Oral Bioavailability. Fitoterapia. 2016;109:274\u2013282. doi: 10.1016/j.fitote.2016.02.001.", "ArticleIdList": ["10.1016/j.fitote.2016.02.001", "26851175"]}, {"Citation": "Och A., Podg\u00f3rski R., Nowak R. Biological Activity of Berberine\u2014A Summary Update. Toxins. 2020;12:713. doi: 10.3390/toxins12110713.", "ArticleIdList": ["10.3390/toxins12110713", "PMC7697704", "33198257"]}, {"Citation": "Neag M.A., Mocan A., Echeverr\u00eda J., Pop R.M., Bocsan C.I., Cri\u015fan G., Buzoianu A.D. Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders. Front. Pharmacol. 2018;9:557. doi: 10.3389/fphar.2018.00557.", "ArticleIdList": ["10.3389/fphar.2018.00557", "PMC6111450", "30186157"]}, {"Citation": "Xiao D., Liu Z., Zhang S., Zhou M., He F., Zou M., Peng J., Xie X., Liu Y., Peng D. Berberine Derivatives with Different Pharmacological Activities via Structural Modifications. Mini Rev. Med. Chem. 2018;18:1424\u20131441. doi: 10.2174/1389557517666170321103139.", "ArticleIdList": ["10.2174/1389557517666170321103139", "28325147"]}, {"Citation": "Kumar A., Chopra K., Mukherjee M., Pottabathini R., Dhull D.K. Current Knowledge and Pharmacological Profile of Berberine: An Update. Eur. J. Pharmacol. 2015;761:288\u2013297. doi: 10.1016/j.ejphar.2015.05.068.", "ArticleIdList": ["10.1016/j.ejphar.2015.05.068", "26092760"]}, {"Citation": "Kim M., Shin M.S., Lee J.M., Cho H.S., Kim C.J., Kim Y.J., Choi H.R., Jeon J.W. Inhibitory Effects of Isoquinoline Alkaloid Berberine on Ischemia-Induced Apoptosis via Activation of Phosphoinositide 3-Kinase/Protein Kinase B Signaling Pathway. Int. Neurourol. J. 2014;18:115. doi: 10.5213/inj.2014.18.3.115.", "ArticleIdList": ["10.5213/inj.2014.18.3.115", "PMC4180161", "25279238"]}, {"Citation": "Zhou X.-Q., Zeng X.-N., Kong H., Sun X.-L. Neuroprotective Effects of Berberine on Stroke Models in Vitro and in Vivo. Neurosci. Lett. 2008;447:31\u201336. doi: 10.1016/j.neulet.2008.09.064.", "ArticleIdList": ["10.1016/j.neulet.2008.09.064", "18838103"]}, {"Citation": "Benaissa F., Mohseni-Rad H., Rahimi-Moghaddam P., Mahmoudian M. Berberine Reduces the Hypoxic-Ischemic Insult in Rat Pup Brain. Acta Physiol. Hung. 2009;96:213\u2013220. doi: 10.1556/APhysiol.96.2009.2.6.", "ArticleIdList": ["10.1556/APhysiol.96.2009.2.6", "19457765"]}, {"Citation": "Liu Y., Zhang L., Song H., Ji G. Update on Berberine in Nonalcoholic Fatty Liver Disease. Evid-Based Complement. Altern. Med. 2013;2013:308134. doi: 10.1155/2013/308134.", "ArticleIdList": ["10.1155/2013/308134", "PMC3703418", "23843872"]}, {"Citation": "Zhang B., Xu D., Guo Y., Ping J., Chen L., Wang H. Protection by and Anti-oxidant Mechanism of Berberine against Rat Liver Fibrosis Induced by Multiple Hepatotoxic Factors. Clin. Exp. Pharmacol. Physiol. 2008;35:303\u2013309. doi: 10.1111/j.1440-1681.2007.04819.x.", "ArticleIdList": ["10.1111/j.1440-1681.2007.04819.x", "17973934"]}, {"Citation": "Chen C., Yu Z., Li Y., Fichna J., Storr M. Effects of Berberine in the Gastrointestinal Tract\u2014A Review of Actions and Therapeutic Implications. Am. J. Chin. Med. 2014;42:1053\u20131070. doi: 10.1142/S0192415X14500669.", "ArticleIdList": ["10.1142/S0192415X14500669", "25183302"]}, {"Citation": "Joshi P.V., Shirkhedkar A.A., Prakash K., Maheshwari V.L. Antidiarrheal Activity, Chemical and Toxicity Profile of Berberis Aristata. Pharm. Biol. 2011;49:94\u2013100. doi: 10.3109/13880209.2010.500295.", "ArticleIdList": ["10.3109/13880209.2010.500295", "20738174"]}, {"Citation": "Zhou M., Deng Y., Liu M., Liao L., Dai X., Guo C., Zhao X., He L., Peng C., Li Y. The Pharmacological Activity of Berberine, a Review for Liver Protection. Eur. J. Pharmacol. 2021;890:173655. doi: 10.1016/j.ejphar.2020.173655.", "ArticleIdList": ["10.1016/j.ejphar.2020.173655", "33068590"]}, {"Citation": "Wang N., Xu Q., Tan H.Y., Hong M., Li S., Yuen M.-F., Feng Y. Berberine Inhibition of Fibrogenesis in a Rat Model of Liver Fibrosis and in Hepatic Stellate Cells. Evid-Based Complement. Altern. Med. 2016;2016:8762345. doi: 10.1155/2016/8762345.", "ArticleIdList": ["10.1155/2016/8762345", "PMC4867075", "27239214"]}, {"Citation": "Sun X., Zhang X., Hu H., Lu Y., Chen J., Yasuda K., Wang H. Berberine Inhibits Hepatic Stellate Cell Proliferation and Prevents Experimental Liver Fibrosis. Biol. Pharm. Bull. 2009;32:1533\u20131537. doi: 10.1248/bpb.32.1533.", "ArticleIdList": ["10.1248/bpb.32.1533", "19721228"]}, {"Citation": "Li J., Pan Y., Kan M., Xiao X., Wang Y., Guan F., Zhang X., Chen L. Hepatoprotective Effects of Berberine on Liver Fibrosis via Activation of AMP-Activated Protein Kinase. Life Sci. 2014;98:24\u201330. doi: 10.1016/j.lfs.2013.12.211.", "ArticleIdList": ["10.1016/j.lfs.2013.12.211", "24412384"]}, {"Citation": "Eissa L.A., Kenawy H.I., El-Karef A., Elsherbiny N.M., El-Mihi K.A. Antioxidant and Anti-Inflammatory Activities of Berberine Attenuate Hepatic Fibrosis Induced by Thioacetamide Injection in Rats. Chem. Biol. Interact. 2018;294:91\u2013100. doi: 10.1016/j.cbi.2018.08.016.", "ArticleIdList": ["10.1016/j.cbi.2018.08.016", "30138605"]}, {"Citation": "Domitrovi\u0107 R., Jakovac H., Marchesi V.V., Bla\u017eekovi\u0107 B. Resolution of Liver Fibrosis by Isoquinoline Alkaloid Berberine in CCl4-Intoxicated Mice Is Mediated by Suppression of Oxidative Stress and Upregulation of MMP-2 Expression. J. Med. Food. 2013;16:518\u2013528. doi: 10.1089/jmf.2012.0175.", "ArticleIdList": ["10.1089/jmf.2012.0175", "PMC3684211", "23734997"]}, {"Citation": "Bansod S., Saifi M.A., Godugu C. Molecular Updates on Berberine in Liver Diseases: Bench to Bedside. Phyther. Res. 2021;35:5459\u20135476. doi: 10.1002/ptr.7181.", "ArticleIdList": ["10.1002/ptr.7181", "34056769"]}, {"Citation": "Cai Z., Wang C., Yang W. Role of Berberine in Alzheimer\u2019s Disease. Neuropsychiatr. Dis. Treat. 2016;12:2509. doi: 10.2147/NDT.S114846.", "ArticleIdList": ["10.2147/NDT.S114846", "PMC5055107", "27757035"]}, {"Citation": "Ji H.-F., Shen L. Berberine: A Potential Multipotent Natural Product to Combat Alzheimer\u2019s Disease. Molecules. 2011;16:6732\u20136740. doi: 10.3390/molecules16086732.", "ArticleIdList": ["10.3390/molecules16086732", "PMC6264702", "21829148"]}, {"Citation": "Singh A.K., Singh S.K., Nandi M.K., Mishra G., Maurya A., Rai A., Rai G.K., Awasthi R., Sharma B., Kulkarni G.T. Berberine: A Plant-Derived Alkaloid with Therapeutic Potential to Combat Alzheimer\u2019s Disease. Cent. Nerv. Syst. Agents Med. Chem. (Formerly Curr. Med. Chem. Nerv. Syst. Agents) 2019;19:154\u2013170. doi: 10.2174/1871524919666190820160053.", "ArticleIdList": ["10.2174/1871524919666190820160053", "31429696"]}, {"Citation": "Akbar M., Shabbir A., Rehman K., Akash M.S.H., Shah M.A. Neuroprotective Potential of Berberine in Modulating Alzheimer\u2019s Disease via Multiple Signaling Pathways. J. Food Biochem. 2021;45:e13936. doi: 10.1111/jfbc.13936.", "ArticleIdList": ["10.1111/jfbc.13936", "34523148"]}, {"Citation": "Kulkarni S.K., Dhir A. Berberine: A Plant Alkaloid with Therapeutic Potential for Central Nervous System Disorders. Phyther. Res. An Int. J. Devoted Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2010;24:317\u2013324. doi: 10.1002/ptr.2968.", "ArticleIdList": ["10.1002/ptr.2968", "19998323"]}, {"Citation": "Kulkarni S.K., Dhir A. On the Mechanism of Antidepressant-like Action of Berberine Chloride. Eur. J. Pharmacol. 2008;589:163\u2013172. doi: 10.1016/j.ejphar.2008.05.043.", "ArticleIdList": ["10.1016/j.ejphar.2008.05.043", "18585703"]}, {"Citation": "Kong L.D., Cheng C.H.K., Tan R.X. Monoamine Oxidase Inhibitors from Rhizoma of Coptis Chinensis. Planta Med. 2001;67:74\u201376. doi: 10.1055/s-2001-10874.", "ArticleIdList": ["10.1055/s-2001-10874", "11270727"]}, {"Citation": "Peng W.-H., Wu C.-R., Chen C.-S., Chen C.-F., Leu Z.-C., Hsieh M.-T. Anxiolytic Effect of Berberine on Exploratory Activity of the Mouse in Two Experimental Anxiety Models: Interaction with Drugs Acting at 5-HT Receptors. Life Sci. 2004;75:2451\u20132462. doi: 10.1016/j.lfs.2004.04.032.", "ArticleIdList": ["10.1016/j.lfs.2004.04.032", "15350820"]}, {"Citation": "Ye M., Fu S., Pi R., He F. Neuropharmacological and Pharmacokinetic Properties of Berberine: A Review of Recent Research. J. Pharm. Pharmacol. 2009;61:831\u2013837. doi: 10.1211/jpp.61.07.0001.", "ArticleIdList": ["10.1211/jpp.61.07.0001", "19589224"]}, {"Citation": "Yoo K.-Y., Hwang I.K., Lim B.O., Kang T.-C., Kim D.-W., Kim S.M., Lee H.Y., Dai Kim J., Won M.H. Berberry Extract Reduces Neuronal Damage and N-Methyl-D-Aspartate Receptor 1 Immunoreactivity in the Gerbil Hippocampus after Transient Forebrain Ischemia. Biol. Pharm. Bull. 2006;29:623\u2013628. doi: 10.1248/bpb.29.623.", "ArticleIdList": ["10.1248/bpb.29.623", "16595891"]}, {"Citation": "Maleki S.N., Aboutaleb N., Souri F. Berberine Confers Neuroprotection in Coping with Focal Cerebral Ischemia by Targeting Inflammatory Cytokines. J. Chem. Neuroanat. 2018;87:54\u201359. doi: 10.1016/j.jchemneu.2017.04.008.", "ArticleIdList": ["10.1016/j.jchemneu.2017.04.008", "PMC5812778", "28495517"]}, {"Citation": "Pulipati V.P., Pannain S. Pharmacotherapy of Obesity in Complex Diseases. Clin. Obes. 2022;12:e12497. doi: 10.1111/cob.12497.", "ArticleIdList": ["10.1111/cob.12497", "34889046"]}, {"Citation": "Badi N., Cruz-Monserrate Z. Cancer Immunoprevention. Springer; Berlin/Heidelberg, Germany: 2022. Murine Model of Obesity-Induced Cancer; pp. 195\u2013201.", "ArticleIdList": ["34993948"]}, {"Citation": "Jiang D., Wang D., Zhuang X., Wang Z., Ni Y., Chen S., Sun F. Berberine Increases Adipose Triglyceride Lipase in 3T3-L1 Adipocytes through the AMPK Pathway. Lipids Health Dis. 2016;15:214. doi: 10.1186/s12944-016-0383-4.", "ArticleIdList": ["10.1186/s12944-016-0383-4", "PMC5148888", "27938388"]}, {"Citation": "Evans R.M., Barish G.D., Wang Y.-X. PPARs and the Complex Journey to Obesity. Nat. Med. 2004;10:355\u2013361. doi: 10.1038/nm1025.", "ArticleIdList": ["10.1038/nm1025", "15057233"]}, {"Citation": "Huang C., Zhang Y., Gong Z., Sheng X., Li Z., Zhang W., Qin Y. Berberine Inhibits 3T3-L1 Adipocyte Differentiation through the PPAR\u03b3 Pathway. Biochem. Biophys. Res. Commun. 2006;348:571\u2013578. doi: 10.1016/j.bbrc.2006.07.095.", "ArticleIdList": ["10.1016/j.bbrc.2006.07.095", "16890192"]}, {"Citation": "Zhou X., Ren F., Wei H., Liu L., Shen T., Xu S., Wei J., Ren J., Ni H. Combination of Berberine and Evodiamine Inhibits Intestinal Cholesterol Absorption in High Fat Diet Induced Hyperlipidemic Rats. Lipids Health Dis. 2017;16:239. doi: 10.1186/s12944-017-0628-x.", "ArticleIdList": ["10.1186/s12944-017-0628-x", "PMC5725942", "29228954"]}, {"Citation": "Wang Y., Yi X., Ghanam K., Zhang S., Zhao T., Zhu X. Berberine Decreases Cholesterol Levels in Rats through Multiple Mechanisms, Including Inhibition of Cholesterol Absorption. Metabolism. 2014;63:1167\u20131177. doi: 10.1016/j.metabol.2014.05.013.", "ArticleIdList": ["10.1016/j.metabol.2014.05.013", "25002181"]}, {"Citation": "Zhang X., Zhao Y., Xu J., Xue Z., Zhang M., Pang X., Zhang X., Zhao L. Modulation of Gut Microbiota by Berberine and Metformin during the Treatment of High-Fat Diet-Induced Obesity in Rats. Sci. Rep. 2015;5:14405. doi: 10.1038/srep14405.", "ArticleIdList": ["10.1038/srep14405", "PMC4585776", "26396057"]}, {"Citation": "Zhang H.Y., Piao X.S., Zhang Q., Li P., Yi J.Q., Liu J.D., Li Q.Y., Wang G.Q. The Effects of Forsythia Suspensa Extract and Berberine on Growth Performance, Immunity, Antioxidant Activities, and Intestinal Microbiota in Broilers under High Stocking Density. Poult. Sci. 2013;92:1981\u20131988. doi: 10.3382/ps.2013-03081.", "ArticleIdList": ["10.3382/ps.2013-03081", "23873544"]}, {"Citation": "Habtemariam S. Berberine Pharmacology and the Gut Microbiota: A Hidden Therapeutic Link. Pharmacol. Res. 2020;155:104722. doi: 10.1016/j.phrs.2020.104722.", "ArticleIdList": ["10.1016/j.phrs.2020.104722", "32105754"]}, {"Citation": "Singh S., Pathak N., Fatima E., Negi A.S. Plant Isoquinoline Alkaloids: Advances in the Chemistry and Biology of Berberine. Eur. J. Med. Chem. 2021;226:113839. doi: 10.1016/j.ejmech.2021.113839.", "ArticleIdList": ["10.1016/j.ejmech.2021.113839", "34536668"]}, {"Citation": "Zhang S., Zhou J., Gober H.-J., Leung W.T., Wang L. Effect and Mechanism of Berberine against Polycystic Ovary Syndrome. Biomed. Pharmacother. 2021;138:111468. doi: 10.1016/j.biopha.2021.111468.", "ArticleIdList": ["10.1016/j.biopha.2021.111468", "33740526"]}, {"Citation": "Wang Z., Nie K., Su H., Tang Y., Wang H., Xu X., Dong H. Berberine Improves Ovulation and Endometrial Receptivity in Polycystic Ovary Syndrome. Phytomedicine. 2021;91:153654. doi: 10.1016/j.phymed.2021.153654.", "ArticleIdList": ["10.1016/j.phymed.2021.153654", "34333328"]}, {"Citation": "Wei W., Zhao H., Wang A., Sui M., Liang K., Deng H., Ma Y., Zhang Y., Zhang H., Guan Y. A Clinical Study on the Short-Term Effect of Berberine in Comparison to Metformin on the Metabolic Characteristics of Women with Polycystic Ovary Syndrome. Eur. J. Endocrinol. 2012;166:99. doi: 10.1530/EJE-11-0616.", "ArticleIdList": ["10.1530/EJE-11-0616", "22019891"]}, {"Citation": "Rondanelli M., Infantino V., Riva A., Petrangolini G., Faliva M.A., Peroni G., Naso M., Nichetti M., Spadaccini D., Gasparri C. Polycystic Ovary Syndrome Management: A Review of the Possible Amazing Role of Berberine. Arch. Gynecol. Obstet. 2020;301:53\u201360. doi: 10.1007/s00404-020-05450-4.", "ArticleIdList": ["10.1007/s00404-020-05450-4", "PMC7028834", "32060683"]}, {"Citation": "Xie L., Zhang D., Ma H., He H., Xia Q., Shen W., Chang H., Deng Y., Wu Q., Cong J. The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials. Evid-Based Complement. Altern. Med. 2019;2019:7918631. doi: 10.1155/2019/7918631.", "ArticleIdList": ["10.1155/2019/7918631", "PMC6930782", "31915452"]}, {"Citation": "Saleem F., Rizvi S.W. New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome. Cureus. 2017;9:e1844. doi: 10.7759/cureus.1844.", "ArticleIdList": ["10.7759/cureus.1844", "PMC5766352", "29344438"]}, {"Citation": "Wang Y., Fu X., Xu J., Wang Q., Kuang H. Systems Pharmacology to Investigate the Interaction of Berberine and Other Drugs in Treating Polycystic Ovary Syndrome. Sci. Rep. 2016;6:28089. doi: 10.1038/srep28089.", "ArticleIdList": ["10.1038/srep28089", "PMC4910093", "27306862"]}, {"Citation": "Yao Y., Chen H., Yan L., Wang W., Wang D. Berberine Alleviates Type 2 Diabetic Symptoms by Altering Gut Microbiota and Reducing Aromatic Amino Acids. Biomed. Pharmacother. 2020;131:110669. doi: 10.1016/j.biopha.2020.110669.", "ArticleIdList": ["10.1016/j.biopha.2020.110669", "32937246"]}, {"Citation": "Dong H., Wang N., Zhao L., Lu F. Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis. Evid-Based Complement. Altern. Med. 2012;2012:591654. doi: 10.1155/2012/591654.", "ArticleIdList": ["10.1155/2012/591654", "PMC3478874", "23118793"]}, {"Citation": "Abascal K., Yarnell E. Recent Clinical Advances with Berberine. Altern. Complement. Ther. 2010;16:281\u2013287. doi: 10.1089/act.2010.16505.", "ArticleIdList": ["10.1089/act.2010.16505"]}, {"Citation": "Chen Y., Wang Y., Zhang J., Sun C., Lopez A. Berberine Improves Glucose Homeostasis in Streptozotocin-Induced Diabetic Rats in Association with Multiple Factors of Insulin Resistance. Int. Sch. Res. Not. 2011;2011:519371. doi: 10.5402/2011/519371.", "ArticleIdList": ["10.5402/2011/519371", "PMC3262646", "22363882"]}, {"Citation": "Xia X., Yan J., Shen Y., Tang K., Yin J., Zhang Y., Yang D., Liang H., Ye J., Weng J. Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis. PLoS ONE. 2011;6:e16556. doi: 10.1371/journal.pone.0016556.", "ArticleIdList": ["10.1371/journal.pone.0016556", "PMC3033390", "21304897"]}, {"Citation": "Yin J., Xing H., Ye J. Efficacy of Berberine in Patients with Type 2 Diabetes Mellitus. Metabolism. 2008;57:712\u2013717. doi: 10.1016/j.metabol.2008.01.013.", "ArticleIdList": ["10.1016/j.metabol.2008.01.013", "PMC2410097", "18442638"]}, {"Citation": "Yang J., Yin J., Gao H., Xu L., Wang Y., Xu L., Li M. Berberine Improves Insulin Sensitivity by Inhibiting Fat Store and Adjusting Adipokines Profile in Human Preadipocytes and Metabolic Syndrome Patients. Evid-Based Complement. Altern. Med. 2012;2012:363845. doi: 10.1155/2012/363845.", "ArticleIdList": ["10.1155/2012/363845", "PMC3310165", "22474499"]}, {"Citation": "Zhang M., Chen L. Berberine in Type 2 Diabetes Therapy: A New Perspective for an Old Antidiarrheal Drug? Acta Pharm. Sin. B. 2012;2:379\u2013386. doi: 10.1016/j.apsb.2012.06.004.", "ArticleIdList": ["10.1016/j.apsb.2012.06.004"]}, {"Citation": "Lee Y.S., Kim W.S., Kim K.H., Yoon M.J., Cho H.J., Shen Y., Ye J.-M., Lee C.H., Oh W.K., Kim C.T. Berberine, a Natural Plant Product, Activates AMP-Activated Protein Kinase with Beneficial Metabolic Effects in Diabetic and Insulin-Resistant States. Diabetes. 2006;55:2256\u20132264. doi: 10.2337/db06-0006.", "ArticleIdList": ["10.2337/db06-0006", "16873688"]}, {"Citation": "Zhang H., Kong W.-J., Shan Y.-Q., Song D.-Q., Li Y., Wang Y.-M., You X.-F., Jiang J.-D. Protein Kinase D Activation Stimulates the Transcription of the Insulin Receptor Gene. Mol. Cell. Endocrinol. 2010;330:25\u201332. doi: 10.1016/j.mce.2010.07.022.", "ArticleIdList": ["10.1016/j.mce.2010.07.022", "20674666"]}, {"Citation": "Jiang S.-J., Dong H., Li J.-B., Xu L.-J., Zou X., Wang K.-F., Lu F.-E., Yi P. Berberine Inhibits Hepatic Gluconeogenesis via the LKB1-AMPK-TORC2 Signaling Pathway in Streptozotocin-Induced Diabetic Rats. World J. Gastroenterol. WJG. 2015;21:7777. doi: 10.3748/wjg.v21.i25.7777.", "ArticleIdList": ["10.3748/wjg.v21.i25.7777", "PMC4491964", "26167077"]}, {"Citation": "Zhang X., Zhao Y., Zhang M., Pang X., Xu J., Kang C., Li M., Zhang C., Zhang Z., Zhang Y. Structural Changes of Gut Microbiota during Berberine-Mediated Prevention of Obesity and Insulin Resistance in High-Fat Diet-Fed Rats. PLoS ONE. 2012;7:e42529. doi: 10.1371/journal.pone.0042529.", "ArticleIdList": ["10.1371/journal.pone.0042529", "PMC3411811", "22880019"]}, {"Citation": "Han J., Lin H., Huang W. Modulating Gut Microbiota as an Anti-Diabetic Mechanism of Berberine. Med. Sci. Monit. Int. Med. J. Exp. Clin. Res. 2011;17:RA164. doi: 10.12659/MSM.881842.", "ArticleIdList": ["10.12659/MSM.881842", "PMC3539561", "21709646"]}, {"Citation": "Yao J., Kong W., Jiang J. Learning from Berberine: Treating Chronic Diseases through Multiple Targets. Sci. China Life Sci. 2015;58:854\u2013859. doi: 10.1007/s11427-013-4568-z.", "ArticleIdList": ["10.1007/s11427-013-4568-z", "24174332"]}, {"Citation": "El Hadri K., Smith R., Duplus E., El Amri C. Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target. Int. J. Mol. Sci. 2021;23:77. doi: 10.3390/ijms23010077.", "ArticleIdList": ["10.3390/ijms23010077", "PMC8744732", "35008500"]}, {"Citation": "Noble C., Carlson K.D., Neumann E., Lewis B., Dragomir-Daescu D., Lerman A., Erdemir A., Young M.D. Finite Element Analysis in Clinical Patients with Atherosclerosis. J. Mech. Behav. Biomed. Mater. 2022;125:104927. doi: 10.1016/j.jmbbm.2021.104927.", "ArticleIdList": ["10.1016/j.jmbbm.2021.104927", "PMC8665142", "34740008"]}, {"Citation": "Mehu M., Narasimhulu C.A., Singla D.K. Inflammatory Cells in Atherosclerosis. Antioxidants. 2022;11:233. doi: 10.3390/antiox11020233.", "ArticleIdList": ["10.3390/antiox11020233", "PMC8868126", "35204116"]}, {"Citation": "Xie X., Ma X., Zeng S., Tang W., Xiao L., Zhu C., Yu R. Mechanisms of Berberine for the Treatment of Atherosclerosis Based on Network Pharmacology. Evid-Based Complement. Altern. Med. 2020;2020:3568756. doi: 10.1155/2020/3568756.", "ArticleIdList": ["10.1155/2020/3568756", "PMC7106879", "32256641"]}, {"Citation": "Frismantiene A., Philippova M., Erne P., Resink T.J. Smooth Muscle Cell-Driven Vascular Diseases and Molecular Mechanisms of VSMC Plasticity. Cell. Signal. 2018;52:48\u201364. doi: 10.1016/j.cellsig.2018.08.019.", "ArticleIdList": ["10.1016/j.cellsig.2018.08.019", "30172025"]}, {"Citation": "Ping S., Liu S., Zhou Y., Li Z., Li Y., Liu K., Bardeesi A.S.A., Wang L., Chen J., Deng L. Protein Disulfide Isomerase-Mediated Apoptosis and Proliferation of Vascular Smooth Muscle Cells Induced by Mechanical Stress and Advanced Glycosylation End Products Result in Diabetic Mouse Vein Graft Atherosclerosis. Cell Death Dis. 2017;8:e2818. doi: 10.1038/cddis.2017.213.", "ArticleIdList": ["10.1038/cddis.2017.213", "PMC5520728", "28542133"]}, {"Citation": "Rui R., Yang H., Liu Y., Zhou Y., Xu X., Li C., Liu S. Effects of Berberine on Atherosclerosis. Front. Pharmacol. 2021;12:764175. doi: 10.3389/fphar.2021.764175.", "ArticleIdList": ["10.3389/fphar.2021.764175", "PMC8661030", "34899318"]}, {"Citation": "Lee S., Lim H.-J., Park J.-H., Lee K.-S., Jang Y., Park H.-Y. Berberine-Induced LDLR up-Regulation Involves JNK Pathway. Biochem. Biophys. Res. Commun. 2007;362:853\u2013857. doi: 10.1016/j.bbrc.2007.08.060.", "ArticleIdList": ["10.1016/j.bbrc.2007.08.060", "17767919"]}, {"Citation": "Abidi P., Zhou Y., Jiang J.-D., Liu J. Extracellular Signal-Regulated Kinase\u2013Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor MRNA by Herbal Medicine Berberine. Arterioscler. Thromb. Vasc. Biol. 2005;25:2170\u20132176. doi: 10.1161/01.ATV.0000181761.16341.2b.", "ArticleIdList": ["10.1161/01.ATV.0000181761.16341.2b", "16100034"]}, {"Citation": "Brusq J.-M., Ancellin N., Grondin P., Guillard R., Martin S., Saintillan Y., Issandou M. Inhibition of Lipid Synthesis through Activation of AMP Kinase: An Additional Mechanism for the Hypolipidemic Effects of Berberine. J. Lipid Res. 2006;47:1281\u20131288. doi: 10.1194/jlr.M600020-JLR200.", "ArticleIdList": ["10.1194/jlr.M600020-JLR200", "16508037"]}, {"Citation": "Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H. Berberine Is a Novel Cholesterol-Lowering Drug Working through a Unique Mechanism Distinct from Statins. Nat. Med. 2004;10:1344\u20131351. doi: 10.1038/nm1135.", "ArticleIdList": ["10.1038/nm1135", "15531889"]}, {"Citation": "Zhang Y., Li X., Zou D., Liu W., Yang J., Zhu N., Huo L., Wang M., Hong J., Wu P. Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine. J. Clin. Endocrinol. Metab. 2008;93:2559\u20132565. doi: 10.1210/jc.2007-2404.", "ArticleIdList": ["10.1210/jc.2007-2404", "18397984"]}, {"Citation": "Cicero A.F.G., Rovati L.C., Setnikar I. Eulipidemic Effects of Berberine Administered Alone or in Combination with Other Natural Cholesterol-Lowering Agents. Arzneimittelforschung. 2007;57:26\u201330. doi: 10.1055/s-0031-1296582.", "ArticleIdList": ["10.1055/s-0031-1296582", "17341006"]}, {"Citation": "Kong W.-J., Wei J., Zuo Z.-Y., Wang Y.-M., Song D.-Q., You X.-F., Zhao L.-X., Pan H.-N., Jiang J.-D. Combination of Simvastatin with Berberine Improves the Lipid-Lowering Efficacy. Metabolism. 2008;57:1029\u20131037. doi: 10.1016/j.metabol.2008.01.037.", "ArticleIdList": ["10.1016/j.metabol.2008.01.037", "18640378"]}, {"Citation": "Vuddanda P.R., Chakraborty S., Singh S. Berberine: A Potential Phytochemical with Multispectrum Therapeutic Activities. Expert Opin. Investig. Drugs. 2010;19:1297\u20131307. doi: 10.1517/13543784.2010.517745.", "ArticleIdList": ["10.1517/13543784.2010.517745", "20836620"]}, {"Citation": "Fatehi-Hassanabad Z., Jafarzadeh M., Tarhini A., Fatehi M. The Antihypertensive and Vasodilator Effects of Aqueous Extract from Berberis Vulgaris Fruit on Hypertensive Rats. Phyther. Res. An Int. J. Devoted to Pharmacol. Toxicol. Eval. Nat. Prod. Deriv. 2005;19:222\u2013225.", "ArticleIdList": ["15934023"]}, {"Citation": "Derosa G., Maffioli P., Cicero A.F.G. Berberine on Metabolic and Cardiovascular Risk Factors: An Analysis from Preclinical Evidences to Clinical Trials. Expert Opin. Biol. Ther. 2012;12:1113\u20131124. doi: 10.1517/14712598.2012.704014.", "ArticleIdList": ["10.1517/14712598.2012.704014", "22780092"]}, {"Citation": "Feng X., Sureda A., Jafari S., Memariani Z., Tewari D., Annunziata G., Barrea L., Hassan S.T.S., \u0160mejkal K., Malan\u00edk M. Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics. Theranostics. 2019;9:1923. doi: 10.7150/thno.30787.", "ArticleIdList": ["10.7150/thno.30787", "PMC6485276", "31037148"]}, {"Citation": "Ko W.-H., Yao X.-Q., Lau C.-W., Law W.-I., Chen Z.-Y., Kwok W., Ho K., Huang Y. Vasorelaxant and Antiproliferative Effects of Berberine. Eur. J. Pharmacol. 2000;399:187\u2013196. doi: 10.1016/S0014-2999(00)00339-3.", "ArticleIdList": ["10.1016/S0014-2999(00)00339-3", "10884519"]}, {"Citation": "Cicero A., Ertek S. Metabolic and Cardiovascular Effects of Berberine: From Preclinical Evidences to Clinical Trial Results. Clin. Lipidol. 2009;4:553\u2013563. doi: 10.2217/clp.09.41.", "ArticleIdList": ["10.2217/clp.09.41"]}, {"Citation": "Kang D.G., Sohn E.J., Kwon E.K., Han J.H., Oh H., Lee H.S. Effects of Berberine on Angiotensin-Converting Enzyme and NO/CGMP System in Vessels. Vascul. Pharmacol. 2002;39:281\u2013286. doi: 10.1016/S1537-1891(03)00005-3.", "ArticleIdList": ["10.1016/S1537-1891(03)00005-3", "14567065"]}, {"Citation": "Caliceti C., Rizzo P., Ferrari R., Fortini F., Aquila G., Leoncini E., Zambonin L., Rizzo B., Calabria D., Simoni P. Novel Role of the Nutraceutical Bioactive Compound Berberine in Lectin-like OxLDL Receptor 1-Mediated Endothelial Dysfunction in Comparison to Lovastatin. Nutr. Metab. Cardiovasc. Dis. 2017;27:552\u2013563. doi: 10.1016/j.numecd.2017.04.002.", "ArticleIdList": ["10.1016/j.numecd.2017.04.002", "28511903"]}, {"Citation": "Knox M., Vinet R., Fuentes L., Morales B., Mart\u00ednez J.L. A Review of Endothelium-Dependent and-Independent Vasodilation Induced by Phytochemicals in Isolated Rat Aorta. Animals. 2019;9:623. doi: 10.3390/ani9090623.", "ArticleIdList": ["10.3390/ani9090623", "PMC6769919", "31470540"]}, {"Citation": "Liang K.-W., Yin S.-C., Ting C.-T., Lin S.-J., Hsueh C.-M., Chen C.-Y., Hsu S.-L. Berberine Inhibits Platelet-Derived Growth Factor-Induced Growth and Migration Partly through an AMPK-Dependent Pathway in Vascular Smooth Muscle Cells. Eur. J. Pharmacol. 2008;590:343\u2013354. doi: 10.1016/j.ejphar.2008.06.034.", "ArticleIdList": ["10.1016/j.ejphar.2008.06.034", "18590725"]}, {"Citation": "Firouzi S., Malekahmadi M., Ghayour-Mobarhan M., Ferns G., Rahimi H.R. Barberry in the Treatment of Obesity and Metabolic Syndrome: Possible Mechanisms of Action. Diabetes, Metab. Syndr. Obes. Targets Ther. 2018;11:699. doi: 10.2147/DMSO.S181572.", "ArticleIdList": ["10.2147/DMSO.S181572", "PMC6233907", "30519065"]}, {"Citation": "Liu W., Tang F., Deng Y., Li X., Lan T., Zhang X., Huang H., Liu P. Berberine Reduces Fibronectin and Collagen Accumulation in Rat Glomerular Mesangial Cells Cultured under High Glucose Condition. Mol. Cell. Biochem. 2009;325:99\u2013105. doi: 10.1007/s11010-008-0024-y.", "ArticleIdList": ["10.1007/s11010-008-0024-y", "19142714"]}, {"Citation": "Cho B.-J., Im E.K., Kwon J.H., Lee K.-H., Shin H.-J., Oh J., Kang S.-M., Chung J.H., Jang Y. Berberine Inhibits the Production of Lysophosphatidylcholine-Induced Reactive Oxygen Species and the ERK1/2 Pathway in Vascular Smooth Muscle Cells. Mol. Cells. 2005;20:429\u2013434.", "ArticleIdList": ["16404160"]}, {"Citation": "Mazza A., Lenti S., Schiavon L., Zuin M., D\u2019Avino M., Ramazzina E., Casiglia E. Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk. Adv. Ther. 2015;32:680\u2013690. doi: 10.1007/s12325-015-0229-x.", "ArticleIdList": ["10.1007/s12325-015-0229-x", "26202829"]}, {"Citation": "Wang J., Guo T., Peng Q., Yue S., Wang S. Berberine via Suppression of Transient Receptor Potential Vanilloid 4 Channel Improves Vascular Stiffness in Mice. J. Cell. Mol. Med. 2015;19:2607\u20132616. doi: 10.1111/jcmm.12645.", "ArticleIdList": ["10.1111/jcmm.12645", "PMC4627566", "26177349"]}, {"Citation": "Luo J., Gu Y., Liu P., Jiang X., Yu W., Ye P., Chao Y., Yang H., Zhu L., Zhou L. Berberine Attenuates Pulmonary Arterial Hypertension via Protein Phosphatase 2A Signaling Pathway Both in Vivo and in Vitro. J. Cell. Physiol. 2018;233:9750\u20139762. doi: 10.1002/jcp.26940.", "ArticleIdList": ["10.1002/jcp.26940", "30078229"]}, {"Citation": "Mujtaba M.A., Akhter M.H., Alam M., Ali M.D., Hussain A. An Updated Review on Therapeutic Potential and Recent Advances in Drug Delivery of Berberine: Current Status and Future Prospect. Curr. Pharm. Biotechnol. 2022;23:60\u201371. doi: 10.2174/1389201022666210208152113.", "ArticleIdList": ["10.2174/1389201022666210208152113", "33557735"]}, {"Citation": "Lau C., Yao X., Chen Z., Ko W., Huang Y. Cardiovascular Actions of Berberine. Cardiovasc. Drug Rev. 2001;19:234\u2013244. doi: 10.1111/j.1527-3466.2001.tb00068.x.", "ArticleIdList": ["10.1111/j.1527-3466.2001.tb00068.x", "11607041"]}, {"Citation": "Caruso L., Nadur N.F., da Fonseca M.B., Peixoto Ferreira L.d.A., Lacerda R.B., Graebin C.S., K\u00fcmmerle A.E. The Design of Multi-Target Drugs to Treat Cardiovascular Diseases: Two (or More) Birds on One Stone. Curr. Top. Med. Chem. 2022;22:366\u2013394. doi: 10.2174/1568026622666220201151248.", "ArticleIdList": ["10.2174/1568026622666220201151248", "35105288"]}, {"Citation": "Zhou Z.-W., Zheng H.-C., Zhao L.-F., Li W., Hou J.-W., Yu Y., Miao P.-Z., Zhu J.-M. Effect of Berberine on Acetylcholine-Induced Atrial Fibrillation in Rabbit. Am. J. Transl. Res. 2015;7:1450.", "ArticleIdList": ["PMC4568800", "26396675"]}, {"Citation": "Jun-xian C., Lu F., Yu-hui D., Yan-li D. The Effect of Berberine on Arrhythmia Caused by Stretch of Isolated Myocardial Infarcted Hearts in Rats. Heart. 2012;98:E84\u2013E85. doi: 10.1136/heartjnl-2012-302920a.220.", "ArticleIdList": ["10.1136/heartjnl-2012-302920a.220"]}, {"Citation": "Cao J., FU L., Sun D. The Effect of Berberine on Arrhythmia Caused by Stretch of Myocardium, in Vitro, of Rats after Myocardial Ischemia. Chin. J. Emerg. Med. 2012;12:683\u2013686."}, {"Citation": "Yu F., Lin M., Zhang W. Inhibition of Berberine on IKr, IKs and IK1 in Thyroxine Induced Cardiomyopathic Guinea Pig Ventricular Myocytes. J. China Pharm. Univ. 2009;40:244\u2013249."}, {"Citation": "Wang L., Yu C., Fu Y., Li Q., Sun Y. Berberine Elicits Anti-arrhythmic Effects via IK1/Kir2. 1 in the Rat Type 2 Diabetic Myocardial Infarction Model. Phyther. Res. 2011;25:33\u201337. doi: 10.1002/ptr.3097.", "ArticleIdList": ["10.1002/ptr.3097", "20623609"]}, {"Citation": "Chen H., Chen Y., Tang Y., Yang J., Wang D., Yu T., Huang C. Berberine Attenuates Spontaneous Action Potentials in Sinoatrial Node Cells and the Currents of Human HCN4 Channels Expressed in Xenopus Laevis Oocytes. Mol. Med. Rep. 2014;10:1576\u20131582. doi: 10.3892/mmr.2014.2377.", "ArticleIdList": ["10.3892/mmr.2014.2377", "25017321"]}, {"Citation": "Mosterd A., Hoes A.W. Clinical Epidemiology of Heart Failure. Heart. 2007;93:1137\u20131146. doi: 10.1136/hrt.2003.025270.", "ArticleIdList": ["10.1136/hrt.2003.025270", "PMC1955040", "17699180"]}, {"Citation": "Song D., Hao J., Fan D. Biological Properties and Clinical Applications of Berberine. Front. Med. 2020;14:564\u2013582. doi: 10.1007/s11684-019-0724-6.", "ArticleIdList": ["10.1007/s11684-019-0724-6", "32335802"]}, {"Citation": "Xiong C., Wu Y., Zhang Y., Wu Z., Chen X., Jiang P., Guo H., Xie K., Wang K., Su S. Protective Effect of Berberine on Acute Cardiomyopathy Associated with Doxorubicin Treatment. Oncol. Lett. 2018;15:5721\u20135729. doi: 10.3892/ol.2018.8020.", "ArticleIdList": ["10.3892/ol.2018.8020", "PMC5840547", "29552206"]}, {"Citation": "Xia L.-M., Luo M.-H. Study Progress of Berberine for Treating Cardiovascular Disease. Chronic Dis. Transl. Med. 2015;1:231\u2013235. doi: 10.1016/j.cdtm.2015.11.006.", "ArticleIdList": ["10.1016/j.cdtm.2015.11.006", "PMC5643735", "29063012"]}, {"Citation": "Li Y., Chen X., Liu H., Luo F., Li G. Effects of Ginseng Total Saponins with Berberine on Plasma Brain Natriuretic Peptide and Ca2+ Concentration in Experimental Rats with Chronic Congestive Heart Failure. China J. Chin. Mater. Medica. 2009;34:324\u2013327.", "ArticleIdList": ["19445159"]}, {"Citation": "Dong S.-F., Hong Y., Liu M., Hao Y.-Z., Yu H.-S., Liu Y., Sun J.-N. Berberine Attenuates Cardiac Dysfunction in Hyperglycemic and Hypercholesterolemic Rats. Eur. J. Pharmacol. 2011;660:368\u2013374. doi: 10.1016/j.ejphar.2011.03.024.", "ArticleIdList": ["10.1016/j.ejphar.2011.03.024", "21458442"]}, {"Citation": "Li Z., Jiang J.-D., Kong W.-J. Berberine Upregulates Hepatic Low-Density Lipoprotein Receptor through Ras-Independent but AMP-Activated Protein Kinase-Dependent Raf-1 Activation. Biol. Pharm. Bull. 2014;37:b14-00412. doi: 10.1248/bpb.b14-00412.", "ArticleIdList": ["10.1248/bpb.b14-00412", "25196457"]}, {"Citation": "Cameron J., Ranheim T., Kulseth M.A., Leren T.P., Berge K.E. Berberine Decreases PCSK9 Expression in HepG2 Cells. Atherosclerosis. 2008;201:266\u2013273. doi: 10.1016/j.atherosclerosis.2008.02.004.", "ArticleIdList": ["10.1016/j.atherosclerosis.2008.02.004", "18355829"]}, {"Citation": "Zhou L., Wang X., Yang Y., Wu L., Li F., Zhang R., Yuan G., Wang N., Chen M., Ning G. Berberine Attenuates CAMP-Induced Lipolysis via Reducing the Inhibition of Phosphodiesterase in 3T3-L1 Adipocytes. Biochim. Biophys. Acta (BBA)-Molecular Basis Dis. 2011;1812:527\u2013535. doi: 10.1016/j.bbadis.2010.10.001.", "ArticleIdList": ["10.1016/j.bbadis.2010.10.001", "20969954"]}, {"Citation": "Li H., Dong B., Park S.W., Lee H.-S., Chen W., Liu J. Hepatocyte Nuclear Factor 1\u03b1 Plays a Critical Role in PCSK9 Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine. J. Biol. Chem. 2009;284:28885\u201328895. doi: 10.1074/jbc.M109.052407.", "ArticleIdList": ["10.1074/jbc.M109.052407", "PMC2781434", "19687008"]}, {"Citation": "Jia Y.-J., Xu R.-X., Sun J., Tang Y., Li J.-J. Enhanced Circulating PCSK9 Concentration by Berberine through SREBP-2 Pathway in High Fat Diet-Fed Rats. J. Transl. Med. 2014;12:103. doi: 10.1186/1479-5876-12-103.", "ArticleIdList": ["10.1186/1479-5876-12-103", "PMC4000533", "24755036"]}, {"Citation": "Wang Y., Zidichouski J.A. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis. Cholesterol. 2018;2018:7173920. doi: 10.1155/2018/7173920.", "ArticleIdList": ["10.1155/2018/7173920", "PMC6051272", "30057809"]}, {"Citation": "Gu L., Li N., Gong J., Li Q., Zhu W., Li J. Berberine Ameliorates Intestinal Epithelial Tight-Junction Damage and down-Regulates Myosin Light Chain Kinase Pathways in a Mouse Model of Endotoxinemia. J. Infect. Dis. 2011;203:1602\u20131612. doi: 10.1093/infdis/jir147.", "ArticleIdList": ["10.1093/infdis/jir147", "21592990"]}, {"Citation": "Choi B.-H., Ahn I.-S., Kim Y.-H., Park J.-W., Lee S.-Y., Hyun C.-K., Do M.-S. Berberine Reduces the Expression of Adipogenic Enzymes and Inflammatory Molecules of 3T3-L1 Adipocyte. Exp. Mol. Med. 2006;38:599\u2013605. doi: 10.1038/emm.2006.71.", "ArticleIdList": ["10.1038/emm.2006.71", "17202835"]}, {"Citation": "Wu M., Wang J., Liu L. Advance of Studies on Anti-Atherosclerosis Mechanism of Berberine. Chin. J. Integr. Med. 2010;16:188\u2013192. doi: 10.1007/s11655-010-0188-7.", "ArticleIdList": ["10.1007/s11655-010-0188-7", "20473748"]}, {"Citation": "Lou T., Zhang Z., Xi Z., Liu K., Li L., Liu B., Huang F. Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes. Inflammation. 2011;34:659\u2013667. doi: 10.1007/s10753-010-9276-2.", "ArticleIdList": ["10.1007/s10753-010-9276-2", "21110076"]}, {"Citation": "Jiang Q., Liu P., Wu X., Liu W., Shen X., Lan T., Xu S., Peng J., Xie X., Huang H. Berberine Attenuates Lipopolysaccharide-Induced Extracelluar Matrix Accumulation and Inflammation in Rat Mesangial Cells: Involvement of NF-\u039aB Signaling Pathway. Mol. Cell. Endocrinol. 2011;331:34\u201340. doi: 10.1016/j.mce.2010.07.023.", "ArticleIdList": ["10.1016/j.mce.2010.07.023", "20674665"]}, {"Citation": "Amasheh M., Fromm A., Krug S.M., Amasheh S., Andres S., Zeitz M., Fromm M., Schulzke J.-D. TNF\u03b1-Induced and Berberine-Antagonized Tight Junction Barrier Impairment via Tyrosine Kinase, Akt and NF\u03baB Signaling. J. Cell Sci. 2010;123:4145\u20134155. doi: 10.1242/jcs.070896.", "ArticleIdList": ["10.1242/jcs.070896", "21062898"]}, {"Citation": "Jeong H.W., Hsu K.C., Lee J.-W., Ham M., Huh J.Y., Shin H.J., Kim W.S., Kim J.B. Berberine Suppresses Proinflammatory Responses through AMPK Activation in Macrophages. Am. J. Physiol. Metab. 2009;296:E955\u2013E964. doi: 10.1152/ajpendo.90599.2008.", "ArticleIdList": ["10.1152/ajpendo.90599.2008", "19208854"]}, {"Citation": "Hsu Y.-Y., Tseng Y.-T., Lo Y.-C. Berberine, a Natural Antidiabetes Drug, Attenuates Glucose Neurotoxicity and Promotes Nrf2-Related Neurite Outgrowth. Toxicol. Appl. Pharmacol. 2013;272:787\u2013796. doi: 10.1016/j.taap.2013.08.008.", "ArticleIdList": ["10.1016/j.taap.2013.08.008", "23954465"]}, {"Citation": "Mirhadi E., Rezaee M., Malaekeh-Nikouei B. Nano Strategies for Berberine Delivery, a Natural Alkaloid of Berberis. Biomed. Pharmacother. 2018;104:465\u2013473. doi: 10.1016/j.biopha.2018.05.067.", "ArticleIdList": ["10.1016/j.biopha.2018.05.067", "29793179"]}, {"Citation": "Mohanraj V.J., Chen Y. Nanoparticles\u2014A review. Trop. J. Pharm. Res. 2006;5:561\u2013573. doi: 10.4314/tjpr.v5i1.14634.", "ArticleIdList": ["10.4314/tjpr.v5i1.14634"]}, {"Citation": "Kayser O., Lemke A., Hernandez-Trejo N. The Impact of Nanobiotechnology on the Development of New Drug Delivery Systems. Curr. Pharm. Biotechnol. 2005;6:3\u20135. doi: 10.2174/1389201053167158.", "ArticleIdList": ["10.2174/1389201053167158", "15727551"]}, {"Citation": "Das S., Chaudhury A. Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery. Aaps Pharmscitech. 2011;12:62\u201376. doi: 10.1208/s12249-010-9563-0.", "ArticleIdList": ["10.1208/s12249-010-9563-0", "PMC3066374", "21174180"]}, {"Citation": "Xue M., Zhang L., Yang M., Zhang W., Li X., Ou Z., Li Z., Liu S., Li X., Yang S. Berberine-Loaded Solid Lipid Nanoparticles Are Concentrated in the Liver and Ameliorate Hepatosteatosis in Db/Db Mice. Int. J. Nanomed. 2015;10:5049. doi: 10.2147/IJN.S84565.", "ArticleIdList": ["10.2147/IJN.S84565", "PMC4531046", "26346310"]}, {"Citation": "Xue M., Yang M., Zhang W., Li X., Gao D., Ou Z., Li Z., Liu S., Li X., Yang S. Characterization, Pharmacokinetics, and Hypoglycemic Effect of Berberine Loaded Solid Lipid Nanoparticles. Int. J. Nanomed. 2013;8:4677. doi: 10.2147/IJN.S51262.", "ArticleIdList": ["10.2147/IJN.S51262", "PMC3862509", "24353417"]}, {"Citation": "Wang L., Li H., Wang S., Liu R., Wu Z., Wang C., Wang Y., Chen M. Enhancing the Antitumor Activity of Berberine Hydrochloride by Solid Lipid Nanoparticle Encapsulation. Aaps Pharmscitech. 2014;15:834\u2013844. doi: 10.1208/s12249-014-0112-0.", "ArticleIdList": ["10.1208/s12249-014-0112-0", "PMC4113611", "24696391"]}, {"Citation": "Sharma N., Zahoor I., Sachdeva M., Subramaniyan V., Fuloria S., Fuloria N.K., Naved T., Bhatia S., Al-Harrasi A., Aleya L. Deciphering the Role of Nanoparticles for Management of Bacterial Meningitis: An Update on Recent Studies. Environ. Sci. Pollut. Res. 2021;28:60459\u201360476. doi: 10.1007/s11356-021-16570-y.", "ArticleIdList": ["10.1007/s11356-021-16570-y", "PMC8452126", "34545518"]}, {"Citation": "Parkin D.M., Bray F.I., Devesa S.S. Cancer Burden in the Year 2000. The Global Picture. Eur. J. Cancer. 2001;37:4\u201366. doi: 10.1016/S0959-8049(01)00267-2.", "ArticleIdList": ["10.1016/S0959-8049(01)00267-2", "11602373"]}, {"Citation": "Meng X.-P., Fan H., Wang Y., Wang Z., Chen T. Anti-Hepatocarcinoma Effects of Berberine-Nanostructured Lipid Carriers against Human HepG2, Huh7, and EC9706 Cancer Cell Lines; Proceedings of the Optics in Health Care and Biomedical Optics VII; Beijing, China. 12\u201314 October 2016; p. 1002417."}, {"Citation": "Wang Z., Wu J., Chen T., Zhou Q., Wang Y. In Vitro and in Vivo Antitumor Efficacy of Berberine-Nanostructured Lipid Carriers against H22 Tumor; Proceedings of the Biophotonics and Immune Responses X, International Society for Optics and Photonics; San Francisco, CA, USA. 7\u201312 February 2015; p. 93240Y."}, {"Citation": "Raju M., Kunde S.S., Auti S.T., Kulkarni Y.A., Wairkar S. Berberine Loaded Nanostructured Lipid Carrier for Alzheimer\u2019s Disease: Design, Statistical Optimization and Enhanced in Vivo Performance. Life Sci. 2021;285:119990. doi: 10.1016/j.lfs.2021.119990.", "ArticleIdList": ["10.1016/j.lfs.2021.119990", "34592234"]}, {"Citation": "Gendy A.M., Elnagar M.R., Allam M.M., Mousa M.R., Khodir A.E., El-Haddad A.E., Elnahas O.S., Fayez S.M., El-Mancy S.S. Berberine-Loaded Nanostructured Lipid Carriers Mitigate Warm Hepatic Ischemia/Reperfusion-Induced Lesion through Modulation of HMGB1/TLR4/NF-\u039aB Signaling and Autophagy. Biomed. Pharmacother. 2022;145:112122. doi: 10.1016/j.biopha.2021.112122.", "ArticleIdList": ["10.1016/j.biopha.2021.112122", "34489150"]}, {"Citation": "Akbarzadeh A., Rezaei-Sadabady R., Davaran S., Joo S.W., Zarghami N., Hanifehpour Y., Samiei M., Kouhi M., Nejati-Koshki K. Liposome: Classification, Preparation, and Applications. Nanoscale Res. Lett. 2013;8:102. doi: 10.1186/1556-276X-8-102.", "ArticleIdList": ["10.1186/1556-276X-8-102", "PMC3599573", "23432972"]}, {"Citation": "Calvo A., Moreno E., Larrea E., Sanmart\u00edn C., Irache J.M., Espuelas S. Berberine-Loaded Liposomes for the Treatment of Leishmania Infantum-Infected BALB/c Mice. Pharmaceutics. 2020;12:858. doi: 10.3390/pharmaceutics12090858.", "ArticleIdList": ["10.3390/pharmaceutics12090858", "PMC7558179", "32916948"]}, {"Citation": "Lin Y.-C., Kuo J.-Y., Hsu C.-C., Tsai W.-C., Li W.-C., Yu M.-C., Wen H.-W. Optimizing Manufacture of Liposomal Berberine with Evaluation of Its Antihepatoma Effects in a Murine Xenograft Model. Int. J. Pharm. 2013;441:381\u2013388. doi: 10.1016/j.ijpharm.2012.11.017.", "ArticleIdList": ["10.1016/j.ijpharm.2012.11.017", "23220078"]}, {"Citation": "Allijn I.E., Czarny B.M.S., Wang X., Chong S.Y., Weiler M., Da Silva A.E., Metselaar J.M., Lam C.S.P., Pastorin G., De Kleijn D.P. V Liposome Encapsulated Berberine Treatment Attenuates Cardiac Dysfunction after Myocardial Infarction. J. Control. Release. 2017;247:127\u2013133. doi: 10.1016/j.jconrel.2016.12.042.", "ArticleIdList": ["10.1016/j.jconrel.2016.12.042", "28065862"]}, {"Citation": "Barbosa-Barros L., Barba C., Rodr\u00edguez G., C\u00f3cera M., Coderch L., L\u00f3pez-Iglesias C., De La Maza A., L\u00f3pez O. Lipid Nanostructures: Self-Assembly and Effect on Skin Properties. Mol. Pharm. 2009;6:1237\u20131245. doi: 10.1021/mp9000734.", "ArticleIdList": ["10.1021/mp9000734", "19432456"]}, {"Citation": "Wang T., Wang N., Song H., Xi X., Wang J., Hao A., Li T. Preparation of an Anhydrous Reverse Micelle Delivery System to Enhance Oral Bioavailability and Anti-Diabetic Efficacy of Berberine. Eur. J. Pharm. Sci. 2011;44:127\u2013135. doi: 10.1016/j.ejps.2011.06.015.", "ArticleIdList": ["10.1016/j.ejps.2011.06.015", "21742030"]}, {"Citation": "Kwon M., Lim D.Y., Lee C.H., Jeon J.-H., Choi M.-K., Song I.-S. Enhanced Intestinal Absorption and Pharmacokinetic Modulation of Berberine and Its Metabolites through the Inhibition of P-Glycoprotein and Intestinal Metabolism in Rats Using a Berberine Mixed Micelle Formulation. Pharmaceutics. 2020;12:882. doi: 10.3390/pharmaceutics12090882.", "ArticleIdList": ["10.3390/pharmaceutics12090882", "PMC7558015", "32957491"]}, {"Citation": "Nagavarma B.V.N., Yadav H.K.S., Ayaz A., Vasudha L.S., Shivakumar H.G. Different Techniques for Preparation of Polymeric Nanoparticles-a Review. Asian J. Pharm. Clin. Res. 2012;5:16\u201323."}, {"Citation": "Vuddanda P.R., Mishra A., Singh S.K., Singh S. Development of Polymeric Nanoparticles with Highly Entrapped Herbal Hydrophilic Drug Using Nanoprecipitation Technique: An Approach of Quality by Design. Pharm. Dev. Technol. 2015;20:579\u2013587. doi: 10.3109/10837450.2014.908302.", "ArticleIdList": ["10.3109/10837450.2014.908302", "24831535"]}, {"Citation": "Chang C.-H., Huang W.-Y., Lai C.-H., Hsu Y.-M., Yao Y.-H., Chen T.-Y., Wu J.-Y., Peng S.-F., Lin Y.-H. Development of Novel Nanoparticles Shelled with Heparin for Berberine Delivery to Treat Helicobacter Pylori. Acta Biomater. 2011;7:593\u2013603. doi: 10.1016/j.actbio.2010.08.028.", "ArticleIdList": ["10.1016/j.actbio.2010.08.028", "20813208"]}, {"Citation": "Lu K.-Y., Lin Y.-C., Lu H.-T., Ho Y.-C., Weng S.-C., Tsai M.-L., Mi F.-L. A Novel Injectable in Situ Forming Gel Based on Carboxymethyl Hexanoyl Chitosan/Hyaluronic Acid Polymer Blending for Sustained Release of Berberine. Carbohydr. Polym. 2019;206:664\u2013673. doi: 10.1016/j.carbpol.2018.11.050.", "ArticleIdList": ["10.1016/j.carbpol.2018.11.050", "30553371"]}, {"Citation": "Sherje A.P., Jadhav M., Dravyakar B.R., Kadam D. Dendrimers: A Versatile Nanocarrier for Drug Delivery and Targeting. Int. J. Pharm. 2018;548:707\u2013720. doi: 10.1016/j.ijpharm.2018.07.030.", "ArticleIdList": ["10.1016/j.ijpharm.2018.07.030", "30012508"]}, {"Citation": "Gupta L., Sharma A.K., Gothwal A., Khan M.S., Khinchi M.P., Qayum A., Singh S.K., Gupta U. Dendrimer Encapsulated and Conjugated Delivery of Berberine: A Novel Approach Mitigating Toxicity and Improving in Vivo Pharmacokinetics. Int. J. Pharm. 2017;528:88\u201399. doi: 10.1016/j.ijpharm.2017.04.073.", "ArticleIdList": ["10.1016/j.ijpharm.2017.04.073", "28533175"]}, {"Citation": "He H., Pham-Huy L.A., Dramou P., Xiao D., Zuo P., Pham-Huy C. Carbon Nanotubes: Applications in Pharmacy and Medicine. Biomed Res. Int. 2013;2013:578290. doi: 10.1155/2013/578290.", "ArticleIdList": ["10.1155/2013/578290", "PMC3806157", "24195076"]}, {"Citation": "Saleemi M.A., Kong Y.L., Yong P.V.C., Wong E.H. An Overview of Recent Development in Therapeutic Drug Carrier System Using Carbon Nanotubes. J. Drug Deliv. Sci. Technol. 2020;59:101855. doi: 10.1016/j.jddst.2020.101855.", "ArticleIdList": ["10.1016/j.jddst.2020.101855"]}, {"Citation": "Lohan S., Raza K., Mehta S.K., Bhatti G.K., Saini S., Singh B. Anti-Alzheimer\u2019s Potential of Berberine Using Surface Decorated Multi-Walled Carbon Nanotubes: A Preclinical Evidence. Int. J. Pharm. 2017;530:263\u2013278. doi: 10.1016/j.ijpharm.2017.07.080.", "ArticleIdList": ["10.1016/j.ijpharm.2017.07.080", "28774853"]}, {"Citation": "Zou Q., Li Y., Zhang L., Zuo Y., Li J., Li J. Antibiotic Delivery System Using Nano-hydroxyapatite/Chitosan Bone Cement Consisting of Berberine. J. Biomed. Mater. Res. Part A Off. J. Soc. Biomater. Jpn. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2009;89:1108\u20131117. doi: 10.1002/jbm.a.32199.", "ArticleIdList": ["10.1002/jbm.a.32199", "18767062"]}, {"Citation": "Lin Y.-H., Lin J.-H., Chou S.-C., Chang S.-J., Chung C.-C., Chen Y.-S., Chang C.-H. Berberine-Loaded Targeted Nanoparticles as Specific Helicobacter Pylori Eradication Therapy: In Vitro and in Vivo Study. Nanomedicine. 2015;10:57\u201371. doi: 10.2217/nnm.14.76.", "ArticleIdList": ["10.2217/nnm.14.76", "25177920"]}, {"Citation": "Zhou Y., Liu S., Peng H., Yu L., He B., Zhao Q. In Vivo Anti-Apoptosis Activity of Novel Berberine-Loaded Chitosan Nanoparticles Effectively Ameliorates Osteoarthritis. Int. Immunopharmacol. 2015;28:34\u201343. doi: 10.1016/j.intimp.2015.05.014.", "ArticleIdList": ["10.1016/j.intimp.2015.05.014", "26002585"]}, {"Citation": "Kapoor R., Singh S., Tripathi M., Bhatnagar P., Kakkar P., Gupta K.C. O-Hexadecyl-Dextran Entrapped Berberine Nanoparticles Abrogate High Glucose Stress Induced Apoptosis in Primary Rat Hepatocytes. PLoS ONE. 2014;9:e89124. doi: 10.1371/journal.pone.0089124.", "ArticleIdList": ["10.1371/journal.pone.0089124", "PMC3930636", "24586539"]}, {"Citation": "Khemani M., Sharon M., Sharon M. Encapsulation of Berberine in Nano-Sized PLGA Synthesized by Emulsification Method. Int. Sch. Res. Not. 2012;2012:187354. doi: 10.5402/2012/187354.", "ArticleIdList": ["10.5402/2012/187354"]}, {"Citation": "Yu F., Ao M., Zheng X., Li N., Xia J., Li Y., Li D., Hou Z., Qi Z., Chen X.D. PEG\u2013Lipid\u2013PLGA Hybrid Nanoparticles Loaded with Berberine\u2013Phospholipid Complex to Facilitate the Oral Delivery Efficiency. Drug Deliv. 2017;24:825\u2013833. doi: 10.1080/10717544.2017.1321062.", "ArticleIdList": ["10.1080/10717544.2017.1321062", "PMC8241132", "28509588"]}, {"Citation": "Mehra M., Sheorain J., Kumari S. Synthesis of Berberine Loaded Polymeric Nanoparticles by Central Composite Design; Proceedings of the AIP Conference Proceedings; Penang, Malaysia. 9\u201311 August 2022; Melville, NY, USA: AIP Publishing LLC; 2016. p. 20060."}, {"Citation": "Dash S., Kumar M., Pareek N. Enhanced Antibacterial Potential of Berberine via Synergism with Chitosan Nanoparticles. Mater. Today Proc. 2020;31:640\u2013645. doi: 10.1016/j.matpr.2020.05.506.", "ArticleIdList": ["10.1016/j.matpr.2020.05.506"]}, {"Citation": "Taebpour M., Arasteh F., Akhlaghi M., Haghirosadat B.F., Oroojalian F., Tofighi D. Fabrication and Characterization of PLGA Polymeric Nanoparticles Containing Berberine and Its Cytotoxicity on Breast Cancer Cell (MCF-7) Nanomed. Res. J. 2021;6:396\u2013408."}, {"Citation": "Silva O.A., Pell\u00e1 M.G., Popat K.C., Kipper M.J., Rubira A.F., Martins A.F., Follmann H.D.M., Silva R. Rod-Shaped Keratin Nanoparticles Extracted from Human Hair by Acid Hydrolysis as Photothermally Triggered Berberine Delivery System. Adv. Powder Technol. 2022;33:103353. doi: 10.1016/j.apt.2021.11.005.", "ArticleIdList": ["10.1016/j.apt.2021.11.005"]}, {"Citation": "Xu H., Yuan X.-D., Shen B.-D., Han J., Lv Q.-Y., Dai L., Lin M.-G., Yu C., Bai J.-X., Yuan H.-L. Development of Poly (N-Isopropylacrylamide)/Alginate Copolymer Hydrogel-Grafted Fabrics Embedding of Berberine Nanosuspension for the Infected Wound Treatment. J. Biomater. Appl. 2014;28:1376\u20131385. doi: 10.1177/0885328213509503.", "ArticleIdList": ["10.1177/0885328213509503", "24163330"]}, {"Citation": "Al-Awady M.J., Fauchet A., Greenway G.M., Paunov V.N. Enhanced Antimicrobial Effect of Berberine in Nanogel Carriers with Cationic Surface Functionality. J. Mater. Chem. B. 2017;5:7885\u20137897. doi: 10.1039/C7TB02262J.", "ArticleIdList": ["10.1039/C7TB02262J", "32264390"]}, {"Citation": "Abo El-Enin H.A., Elkomy M.H., Naguib I.A., Ahmed M.F., Alsaidan O.A., Alsalahat I., Ghoneim M.M., Eid H.M. Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route. Pharmaceuticals. 2022;15:281. doi: 10.3390/ph15030281.", "ArticleIdList": ["10.3390/ph15030281", "PMC8955068", "35337079"]}, {"Citation": "Deng J., Wu Z., Zhao Z., Wu C., Yuan M., Su Z., Wang Y., Wang Z. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis. Int. J. Nanomed. 2020;15:3937. doi: 10.2147/IJN.S247406.", "ArticleIdList": ["10.2147/IJN.S247406", "PMC7280064", "32581538"]}, {"Citation": "Yin J., Hou Y., Yin Y., Song X. Selenium-Coated Nanostructured Lipid Carriers Used for Oral Delivery of Berberine to Accomplish a Synergic Hypoglycemic Effect. Int. J. Nanomed. 2017;12:8671. doi: 10.2147/IJN.S144615.", "ArticleIdList": ["10.2147/IJN.S144615", "PMC5724418", "29263662"]}, {"Citation": "Luo X., Li J., Guo L., Cheng X., Zhang T., Deng Y. Preparation of Berberine Hydrochloride Long-Circulating Liposomes by Ionophore A23187-Mediated ZnSO4 Gradient Method. Asian J. Pharm. Sci. 2013;8:261\u2013266. doi: 10.1016/j.ajps.2013.09.009.", "ArticleIdList": ["10.1016/j.ajps.2013.09.009"]}, {"Citation": "Nguyen T.X., Huang L., Liu L., Abdalla A.M.E., Gauthier M., Yang G. Chitosan-Coated Nano-Liposomes for the Oral Delivery of Berberine Hydrochloride. J. Mater. Chem. B. 2014;2:7149\u20137159. doi: 10.1039/C4TB00876F.", "ArticleIdList": ["10.1039/C4TB00876F", "32261793"]}, {"Citation": "Sailor G., Seth A.K., Parmar G., Chauhan S., Javia A. Formulation and in Vitro Evaluation of Berberine Containing Liposome Optimized by 32 Full Factorial Designs. J. Appl. Pharm. Sci. 2015;5:23\u201328. doi: 10.7324/JAPS.2015.50704.", "ArticleIdList": ["10.7324/JAPS.2015.50704"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "3"}, {"Year": "2022", "Month": "6", "Day": "3"}, {"Year": "2022", "Month": "6", "Day": "7"}, {"Year": "2022", "Month": "6", "Day": "24", "Hour": "1", "Minute": "32"}, {"Year": "2022", "Month": "6", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "9"}], "PublicationStatus": "epublish", "ArticleIdList": ["35744831", "PMC9229453", "10.3390/molecules27123705", "molecules27123705"]}}], "PubmedBookArticle": []}